Beyond viability
Why preserving functional performance of T-cells is essential
White paper
Pentahibe Complete
- the high-performance cryopreservation solution for advanced immunotherapy
White paper
Pentahibe Complete
- the high-performance cryopreservation solution for advanced immunotherapy
Cryopreservation performance is often assessed by post-thaw viability. While this provides a useful starting point, it does not fully capture how well T-cells retain their functional properties after thaw. This places particular importance on how cryopreservation conditions are defined and characterized during development.
Download the white paper today to learn more about how Pentahibe Complete preserves viability, recovery and functional immune response – with 80% less DMSO.*
Why Pentahibe
Pentahibe
Proven performance
with 80% less DMSO
PentaHibe Complete delivers comparable post-thaw viability, recovery and functionality to conventional 10% DMSO formulations, with just 2% DMSO.
Ready to use.
Easy to integrate.
PentaHibe Complete is a ready-to-use cryopreservation medium that simplifies preparation and integrates easily into existing workflows, eliminating the need for in-house formulation and helping reduce preparation steps and variability.
Built for regulatory
requirements
Manufactured in compliance with cGMP, PentaHibe Complete is backed by comprehensive quality documentation and Pharmacosmos expertise to support customer qualification, development and regulatory submission activities.
Safe alternatives exists today and we are committed to moving the field toward a future where cryopreservation is both safe and effective - without compromise.
PentaHibe®Complete
Ready-to-use
10% pentaisomaltose
2% DMSO
50 mL.
* PentaHibe Complete (with 2% DMSO) vs a commercial cryopreservation product containing 10% DMSO.
1. Haastrup EW et al. Transplantation and Vpheresis Science, 2021; Vol 60(4): 103138.
2. Svalgaard JD et al. Cryobiology, 2020; Vol 96(01): 207-213.
